Saralasin

Product Name:Saralasin

Synonyms:(Sar1,Val5,Ala8)-Angiotensin II ；H-Sar-Arg-Val-Tyr-Val-His-Pro-Ala-OH

CAS No.:34273-10-4

Catalog No.:GT-M1357

Sequence:H-Sar-Arg-Val-Tyr-Val-His-Pro-Ala-OH

Molecular Formula:C42H65N13O10

Molecular Weight:912.06

Key Specification:

Appearance: White powder
Purity(HPLC): ≥98.0%
Single Impurity(HPLC): ≤1.0%
Acetate Content(HPLC): 5.0%～12.0%
Water Content (Karl Fischer): ≤10.0%

Package: 500mg,1g, 5g, 10g, 20g, 50g, 100g, 200g, 500g

Description:

Saralasin is a peptide composed of 8 amino acids. The sequence contains the unnatural amino acid Sar, which can be used for the differential diagnosis of hypertension. Saralasin has a significant effect on lowering blood pressure in patients with hypertension caused by high plasma angiotensin II levels.

Other services:

Hangzhou Gutuo Biotechnology Co., Ltd. Customized peptide synthesis business:

Custom peptide, peptide drug clinical peptide, order books, beauty peptide, peptide, polypeptide, detecting peptide, peptide reagents, antigenic peptides, starch, aldehyde peptide, cyclic peptide and disulfide bond bypass peptide, a peptide membranes and all kinds of antibacterial peptides, directories, peptide, phosphorylated peptide, peptide, coupling PEG BSA and KLH antigen peptide, all kinds of acid modified peptides, a variety of amine compounds modified peptides, all kinds of fluorescence labeling peptides, parity.Development and transfer of peptide and peptide technology.

MG, G, KG packaging, from R & D customization to enterprise scale production are able to provide, specific need to consult or order, if you need other peptide synthesis for the synthesis of amino acid derivatives, welcome to call, write to Gutuo Biology, we can help you with customized synthesis.

Statement:

Sales of the products of the company belongs to the raw materials, only for related qualification enterprise or unit sales, our company provide products only for scientific research, laboratory, not personal selling, more can not be eaten, product efficacy and potential application of agencies involved are from the published literature, not assessed by state food and drug administration, for reference only.No factual evidence.

Quantity is different, the region is different, the product demand is different the price will be different, please kiss must carefully ask clear.